SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
REXN
--
0.00%
--
Rexahn bails on cancer candidate RX-5902 in triple negative breast cancer
Seeking Alpha - Article · 04/09 10:53
Rexahn 8-K Shows Co. Notified Merck Sharp & Dohme On Apr. 7 Of Termination Of Clinical Trial Collaboration, Supply Deal Related To RX-5902 For Breast Cancer
Benzinga · 04/09 10:22
Does The Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) Share Price Tend To Follow The Market?
Simply Wall St. · 04/08 17:32
Rexahn Pharma Shares See Spike In Volume; Hearing Co. Granted US Patent '101 For 'Quinoxalinyl-piperazinamide methods of use'
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10570101.PN.&OS=PN/10570101&RS=PN/10570101
Benzinga · 02/25 15:10
CYBR, BBBY among premarket losers
Seeking Alpha - Article · 02/12 14:17
Mid-Afternoon Market Update: Dow Rises 50 Points; Sprint Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded up 0.18% to 29327 while the NASDAQ rose 0.67% to 9,693.02. The S&P also rose, gaining 0.48% to 3,368.03.
Benzinga · 02/11 19:34
s, REXN, DBD and PYX among midday movers
Seeking Alpha - Article · 02/11 17:37
Mid-Day Market Update: Amkor Technology Surges On Upbeat Q4 Results; Phio Pharmaceuticals Shares Plummet
Midway through trading Tuesday, the Dow traded up 0.19% to 29,333.28 while the NASDAQ rose 0.8% to 9,705.16. The S&P also rose, gaining 0.54% to 3,370.08.
Benzinga · 02/11 17:08
Rexahn up 76% on RX-0201 license deal
Seeking Alpha - Article · 02/11 16:17
Mid-Morning Market Update: Markets Open Higher; Hasbro Profit Beats Expectations
Following the market opening Tuesday, the Dow traded up 0.36% to 29381.31 while the NASDAQ rose 0.67% to 9692.60. The S&P also rose, gaining 0.56% to 3,370.91.
Benzinga · 02/11 15:14
S, TMUS among premarket gainers
Seeking Alpha - Article · 02/11 14:18
Rexahn Pharmaceuticals Says On Feb. 8 Entered Exclusive License Agreement With Zhejiang HaiChang Biotechnology; Separately Co. Says It Has Continued With Process To Explore And Evaluate Strategic Alternatives
On February 8, 2020, Rexahn Pharmaceuticals, Inc. (the “Company”) entered into an Exclusive License Agreement (the “License Agreement”) with Zhejiang HaiChang Biotechnology Co., Ltd., a Chinese
Benzinga · 02/10 21:59
The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 20)
Benzinga · 11/21/2019 12:22
Rexahn up 52% on encouraging RX-5902 data
Seeking Alpha - Article · 11/01/2019 16:54
ANET, PINS, CRC and REXN among midday movers
Seeking Alpha - Article · 11/01/2019 16:41
Rexahn Pharma Shares Down 11% From Session High But Still Up 49% For Session; Data Highlighted In 'Molecular Cancer Therapeutics' Nov. Issue Was Previously Reported On Sep. 5, 2019
https://mct.aacrjournals.org/content/early/2019/09/05/1535-7163.MCT-18-1334
Benzinga · 11/01/2019 15:53
Rexahn Pharma Shares Up 33%; Traders Recently Circulate Data Published In Molecular Cancer Therapeutics 'RX-5902 Inhibits ß-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer'
https://mct.aacrjournals.org/content/18/11/1916 https://twitter.com/BioRunUp/status/1190289991693262848
https://twitter.com/BioRunUp/status/1190289991693262848 · 11/01/2019 15:37
The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 24)
Benzinga · 10/25/2019 11:12
The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Oct. 16.)
Benzinga · 10/17/2019 11:39
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday morning, 87 companies achieved new lows for the year.
Benzinga · 10/16/2019 14:55